科研级 Leronlimab, Anti-CD195 Recombinant Antibody, Research Grade Leronlimab
Molecular Name
Leronlimab
Size
1mg, 5mg
CAS Number
674782-26-4
Isotype
IgG4 Kappa
Clonality
Monoclonal
Concentration
1mg/ml
Source
CHO Cells
Purity
≥95% as determined by SDS-PAGE
Buffer
Supplied in PBS, PH7.5
Target
CCR5/CD195[Homo sapiens]
Background
Leronlimab (codenamed PRO 140) is a humanized monoclonal antibody targeted against the CCR5 receptor found on T lymphocytes of the human immune system. It is being investigated as a potential therapy in the treatment of COVID-19, triple negative breast cancer, and HIV infection.